2 Minnesota companies work on drug-coated balloons

02/15/2009 | Star Tribune (Minneapolis-St. Paul, Minn.)

Lutonix and Possis Medical are separately working to develop drug-coated balloons that could serve as a lower-cost alternative to drug-eluting stents used in treating vascular diseases. Lutonix plans to begin clinical trials in Europe for its device this year and hopes to secure FDA approval by 2014. A spokesman for Possis Medical said the company plans to begin a clinical study of its product in the U.S. in the "near future."

View Full Article in:

Star Tribune (Minneapolis-St. Paul, Minn.)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Financial Officer
B. E. Smith
Miramar, FL
Director of ASO Department
Bluegrass Family Health
Lexington-or could be in Nashville, TN, KY
Claims Director
PacificSource
Springfield, OR
Mgr NGS Provider Enrollment (I)
National Government Services - WellPoint
Harrisburg, PA
NGS Provider Enrollment Rep
National Government Services - WellPoint
Harrisburg, PA